Skip to main content
. 2017 Dec 30;9(6):527–534. doi: 10.5114/jcb.2017.72605

Table 2.

Therapeutic efficacy of the implantation of radioactive 125I seeds for 182 patients at the 6-month follow-up [n (%)]

Stage CR PR SD PD
III A, 26 (14) 10 (38) 16 (62) 0 (0) 0 (0)
III B, 156 (86) 19 (12) 125 (80) 8 (5) 4 (3)
In all, 182 (100) 29 (16) 141 (90) 8 (4) 4 (2)

CR – complete remission, PR – partial remission, PD – progressive disease, SD – stable disease

CR+PR of patients with stage III A NSCLC is higher than that of patients with III B NSCLC (100%: 92% × 2 = 3.38; p = 0.000)